of Pulmonary Embolism: A Systematic Review and Meta-Analysis of Modern Literature. Clin Appl Thromb Hemost. 2017 Oct;23(7):821-829. \[[PubMed: 27481877](https://pubmed.ncbi.nlm.nih.gov/27481877)\] 74. Bajaj NS, Kalra R, Arora P, Ather S, Guichard JL, Lancaster WJ, Patel N, Raman F, Arora G, Al Solaiman F, Clark DT, Dell'Italia LJ, Leesar MA, Davies JE, McGiffin DC, Ahmed MI. Catheter-directed treatment for acute pulmonary embolism: Systematic review and single-arm meta-analyses. Int J Cardiol. 2016 Dec 15;225:128-139. \[[PubMed: 27718446](https://pubmed.ncbi.nlm.nih.gov/27718446)\] 75. Lee T, Itagaki S, Chiang YP, Egorova NN, Adams DH, Chikwe J. Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013. J Thorac Cardiovasc Surg. 2018 Mar;155(3):1084-1090.e12. \[[PubMed: 28942971](https://pubmed.ncbi.nlm.nih.gov/28942971)\] 76. Keeling WB, Sundt T, Leacche M, Okita Y, Binongo J, Lasajanak Y, Aklog L, Lattouf OM., SPEAR Working Group. Outcomes After Surgical Pulmonary Embolectomy for Acute Pulmonary Embolus: A Multi-Institutional Study. Ann Thorac Surg. 2016 Nov;102(5):1498-1502. \[[PubMed: 27373187](https://pubmed.ncbi.nlm.nih.gov/27373187)\] 77. Pasrija C, Kronfli A, Rouse M, Raithel M, Bittle GJ, Pousatis S, Ghoreishi M, Gammie JS, Griffith BP, Sanchez PG, Kon ZN. Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: A single-center experience. J Thorac Cardiovasc Surg. 2018 Mar;155(3):1095-1106.e2. \[[PubMed: 29452460](https://pubmed.ncbi.nlm.nih.gov/29452460)\] 78. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005 Jul 19;112(3):416-22. \[[PubMed: 16009794](https://pubmed.ncbi.nlm.nih.gov/16009794)\] 79. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P., Warfarin Optimal Duration Italian Trial Investigators. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med. 2003 Jul 01;139(1):19-25. \[[PubMed: 12834314](https://pubmed.ncbi.nlm.nih.gov/12834314)\] 80. Campbell IA, Bentley DP, Prescott RJ, Routledge PA, Shetty HG, Williamson IJ. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ. 2007 Mar 31;334(7595):674. \[[PMC free article: PMC1839169](/pmc/articles/PMC1839169/)\] \[[PubMed: 17289685](https://pubmed.ncbi.nlm.nih.gov/17289685)\] 81. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, LÃ¤rfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995 Jun 22;332(25):1661-5. \[[PubMed: 7760866](https://pubmed.ncbi.nlm.nih.gov/7760866)\] 82. Boutitie F, Pinede L, Schulman S, Agnelli G, Raskob G, Julian J, Hirsh J, Kearon C. Influence